Literature DB >> 15372168

[Unclear liver fibrosis in a 42-year-old patient with polycythemia vera].

F Gundling1, F Kreth, M Tröltzsch, A Tannapfel, H Bödeker, J Mössner.   

Abstract

A 42-year-old patient was admitted to hospital because of ascites and polyglobulia. Laboratory tests revealed reduced liver function and a significant elevation of all three hematopoietic cell lines. Liver fibrosis and polycythemia vera were diagnosed by histologic examination. The most frequent causes for liver fibrosis were serologically excluded. Ultrasound combined with Doppler imaging revealed an obstruction of the right hepatic vein, which was indicative of Budd-Chiari syndrome. BCS can occur under fulminant and nonfulminant conditions, which can result in progressive damage of the liver. Phlebotomy and combined therapy with low-dose aspirin and anagrelide achieved permanent reduction of the elevated blood parameters. In the follow-up the patient's clinical course was stable without hepatic decompensation.

Entities:  

Mesh:

Year:  2004        PMID: 15372168     DOI: 10.1007/s00108-004-1271-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  15 in total

Review 1.  Current management in polycythemia vera.

Authors:  H S Gilbert
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

Review 2.  Budd-Chiari syndrome: a review by an expert panel.

Authors:  Harry L A Janssen; Juan-Carlos Garcia-Pagan; Elwyn Elias; Gilles Mentha; Antoine Hadengue; Dominique-Charles Valla
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

Review 3.  The Budd-Chiari syndrome.

Authors:  K V Narayanan Menon; Vijay Shah; Patrick S Kamath
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

4.  Diagnosis and treatment of the Budd-Chiari syndrome in polycythaemia vera.

Authors:  D CANTWELL; O FITZGERALD; P FITZGERALD; J A MEHIGAN
Journal:  Br Med J       Date:  1956-12-08

5.  Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.

Authors:  Jason M Melear; Robert M Goldstein; Marlon F Levy; Ernesto P Molmenti; Barry Cooper; George J Netto; Goran B Klintmalm; Marvin J Stone
Journal:  Transplantation       Date:  2002-10-27       Impact factor: 4.939

Review 6.  Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.

Authors:  A Wehmeier; T Südhoff; F Meierkord
Journal:  Semin Thromb Hemost       Date:  1997       Impact factor: 4.180

7.  [Oral contraceptives and blood diseases are the most common causes of Budd-Chiari syndrome].

Authors:  S Almer; G Bodemar; B O Rydén; J Elfström; L Franzén; I Ihse; M Resjö
Journal:  Lakartidningen       Date:  1989-11-15

8.  Early medical treatment is life saving in acute Budd-Chiari due to polycythemia vera.

Authors:  Süleyman S Karti; Mustafa Yilmaz; Polat Kosucu; Elif Altun; Jale Kesen; Mehmet Arslan; Orhan Ozgur; Ercüment Ovali
Journal:  Hepatogastroenterology       Date:  2003 Mar-Apr

Review 9.  Hepatic circulatory diseases associated with chronic myeloid disorders.

Authors:  Vijayrama Poreddy; Laurie D DeLeve
Journal:  Clin Liver Dis       Date:  2002-11       Impact factor: 6.126

10.  Efficacy and safety of low-dose aspirin in polycythemia vera.

Authors:  Raffaele Landolfi; Roberto Marchioli; Jack Kutti; Heinz Gisslinger; Gianni Tognoni; Carlo Patrono; Tiziano Barbui
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.